Mouse GM-CSF/CSF2 enzyme-linked immunoassay kit
| Specification | 96 Test |
|---|---|
| Sensitivity | 0.48 pg/ml (10 μl) |
| Standard Curve Range | 1.37~1000 pg/ml |
| Standard Curve Gradient | 7 Points/3 Folds |
| Number of Incubations | 2 |
| Detectable sample | Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc. |
| Sample Volume | 10 μl |
| Type | Fully Ready-to-Use |
| Operation Duration | 120min |
| pg/ml | O.D. | Average | Corrected | |
|---|---|---|---|---|
| 0.00 | 0.0110 | 0.0112 | 0.0111 | |
| 1.37 | 0.0157 | 0.0179 | 0.0168 | 0.0057 |
| 4.12 | 0.0294 | 0.0289 | 0.0292 | 0.0181 |
| 12.35 | 0.0728 | 0.0767 | 0.0748 | 0.0637 |
| 37.04 | 0.2205 | 0.2186 | 0.2196 | 0.2085 |
| 111.11 | 0.5898 | 0.6276 | 0.6087 | 0.5976 |
| 333.33 | 1.5610 | 1.5660 | 1.5635 | 1.5524 |
| 1000.00 | 2.8900 | 2.8870 | 2.8885 | 2.8774 |
Precision
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample Number | S1 | S2 | S3 | S1 | S2 | S3 |
| 22 | 22 | 22 | 6 | 6 | 6 | |
| Average(pg/ml) | 13.4 | 84.9 | 289.1 | 14.3 | 78.5 | 315.9 |
| Standard Deviation | 0.6 | 2.9 | 13.2 | 0.57 | 2.5 | 14.9 |
| Coefficient of Variation(%) | 4.8 | 3.4 | 4.6 | 3.9 | 3.2 | 4.7 |
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested Twenty-two times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of mouse GM-CSF/CSF2 into health mouse serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 80% to 110% with an overall mean recovery of 92%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | n.d.-7.02 | 50.0 | 1.04 |
Serum/Plasma – Thirty samples from apparently healthy mice were evaluated for the presence of GM-CSF/CSF2 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.
Product Data Sheet
Background: GM-CSF/CSF2
GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) induces the development of monocytes, neutrophils, eosinophils, and myeloid and dermal dendritic cells. It also acts as a neutrophil and dendritic cell chemoattractant. GM-CSF promotes Th1 and Th17 cell mediated autoimmune inflammation as well as the inflammatory activation of dendritic cells, microglia, alveolar macrophages, and eosinophils. In addition, it cooperates with G-CSF in promoting tumor cell proliferation and invasion. GM-CSF signals through a receptor complex composed of GM-CSF R alpha and the Common beta Chain (beta c) with Syndecan-2 as a potential co-receptor. The beta c subunit is shared by the receptor complexes for IL-3 and IL-5.
